CVE:MPH

Medicure - MPH Stock Forecast, Price & News

C$1.15

+0.04 (+3.60%)

(As of 11/30/2022 05:20 PM ET)

Add

Compare

Today's Range: C$1.15
▼
C$1.15
50-Day Range: C$0.96
▼
C$1.15
52-Week Range: C$0.80
▼
C$1.50

Volume: 100 shs
Average Volume: 5,310 shs
Market Capitalization: C$11.79 million

P/E Ratio: 12.78
Dividend Yield: N/A
Price Target: N/A

About Medicure

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure. Further, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail pharmacies, as well as online. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

Receive MPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

MPH Stock News Headlines

August 29, 2022 | reuters.com

MPH.V - Medicure Inc | Stock Price & Latest News | Reuters

June 20, 2022 | finance.yahoo.com

MEDICURE ANNOUNCES RESULTS OF 2022 AGM

November 22, 2021 | baystreet.ca

Platform Launch Allowing Americans Access to Canadian Medications

November 22, 2021 | finance.yahoo.com

Medicure Plans To Launch Innovative E-Commerce Pharmacy Platform Offering Hundreds of Medications Directly To Millions of Americans

April 30, 2021 | ca.finance.yahoo.com

Apple Revenue Soars 54% In Q2 On Favorable Covid Comparisons; Profit Smashes Wall Street Forecasts

March 10, 2021 | ca.finance.yahoo.com

British athletes urged to follow Keely Hodgkinson’s example and to show no fear

March 10, 2021 | sg.finance.yahoo.com

Tesla loses a third of its value for the third time in a year

March 10, 2021 | sg.finance.yahoo.com

Priyanka Chopra announces new project happening this month

March 10, 2021 | ca.finance.yahoo.com

Oprah Wore a Super Rare Pair of Glasses During the Meghan and Harry Interview — but We Found 7 Near-Perfect Dupes

November 21, 2020 | reuters.com

Gland Pharma Ltd

August 24, 2020 | benzinga.com

Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports

June 29, 2020 | finance.yahoo.com

Medicure Announces Normal Course Issuer Bid

June 29, 2020 | www.baystreet.ca

Health-Care Issues Prove Robust on Final Monday of June

May 6, 2020 | finance.yahoo.com

Medicure Q1 2020 results and conference call dates

April 22, 2020 | finance.yahoo.com

Time To Worry? One Analyst Just Downgraded Their Medicure Inc. (CVE:MPH) Outlook

March 17, 2020 | www.bloomberg.com

Medicure Announces Completion of Enrollment for FABOLUS-FASTER, Phase 4 Clinical Trial of Aggrastat (Tirofiban Hydrochloride) I

September 5, 2019 | finance.yahoo.com

Why Medicure Inc.'s (CVE:MPH) CEO Pay Matters To You

August 2, 2019 | markets.businessinsider.com

Medicure Q2 2019 Results and Conference Call Dates

July 18, 2019 | finance.yahoo.com

How Medicure Inc. (CVE:MPH) Can Impact Your Portfolio Volatility

June 27, 2019 | finance.yahoo.com

Medicure Announces Results of 2019 Annual Meeting of Shareholders

June 11, 2019 | finance.yahoo.com

Medicure Announces Appoinment of Dr. Neil Owens as President and Chief Operating Officer

May 29, 2019 | ca.finance.yahoo.com

Medicure Inc. (MPH.V)

April 19, 2019 | finance.yahoo.com

The Medicure (CVE:MPH) Share Price Has Gained 224%, So Why Not Pay It Some Attention?

February 13, 2019 | www.marketwatch.com

Medicure Provides Update on Release of Holdback Funds from Apicore Sale

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive MPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

MPH Company Calendar

Last Earnings: 5/24/2017
Today: 12/01/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: CVE
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: CVE:MPH
CUSIP: N/A
CIK: N/A
Web: www.medicure.com
Phone: +1-204-4877412
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 12.78
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 5.47
Current Ratio: 1.47
Quick Ratio: 1.08

Sales & Book Value

Annual Sales: C$23.19 million
Price / Sales: 0.51
Cash Flow: C$0.49 per share
Price / Cash Flow: 2.34
Book Value: C$1.81 per share
Price / Book: 0.63

Miscellaneous

Outstanding Shares: 10,251,000
Free Float: N/A
Market Cap: C$11.79 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Dr. Albert David Friesen Ph.D. (Age 75)
Founder, CEO & Chairman of the board
Comp: $302.06k

Dr. Neil Owens Ph.D.
Pres & COO

Mr. Haaris Uddin B.Com.
CPA, Chief Financial Officer

Dr. Reuben Saba Ph.D.
VP of Scientific & Medical Affairs

Ms. Jamie Gowryluk
VP of Commercial Operations

Key Competitors

View All Competitors

MPH Stock - Frequently Asked Questions

How have MPH shares performed in 2022?: Medicure's stock was trading at C$0.92 on January 1st, 2022. Since then, MPH stock has increased by 25.0% and is now trading at C$1.15.
View the best growth stocks for 2022 here.
How were Medicure's earnings last quarter?: Medicure Inc. (CVE:MPH) released its quarterly earnings data on Wednesday, May, 24th. The company reported ($0.33) earnings per share for the quarter, missing the consensus estimate of $0.04 by $0.37. The business had revenue of $8.71 million for the quarter, compared to the consensus estimate of $14.50 million.
What other stocks do shareholders of Medicure own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Medicure investors own include Dollarama (DOL), Alimentation Couche-Tard (ATD.B), Canoe EIT Income Fund (ENDTF), ProMetic Life Sciences (PLI), Hudbay Minerals (HBM), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Detour Gold (DGC), Sinovac Biotech (SVA) and Viking Therapeutics (VKTX).

What is Medicure's stock symbol?: Medicure trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MPH."
How do I buy shares of Medicure?: Shares of MPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is Medicure's stock price today?: One share of MPH stock can currently be purchased for approximately C$1.15.
How much money does Medicure make?: Medicure (CVE:MPH) has a market capitalization of C$11.79 million and generates C$23.19 million in revenue each year.
How can I contact Medicure?: Medicure's mailing address is 1250 Waverley St Suite 2, WINNIPEG, MB R3T 6C6, Canada. The official website for the company is www.medicure.com. The company can be reached via phone at +1-204-4877412.

This page (CVE:MPH) was last updated on 12/1/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial